Daniel W Lin

6PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|Aug 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.

Michael A Liss, Nicole Zeltser, Yingye Zheng

|Oct 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.

Ailin Zhang, Nathan A Lau, Alicia Wong

|Jan 11, 2022
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.

Heiko Schöder, Thomas A Hope, Michael Knopp

|Oct 13, 2020
Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?

Maha Hussain, Daniel Lin, Fred Saad

|Aug 12, 2020
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.

Neal D Shore, Charles G Drake, Daniel W Lin

Pageof 1

Frequent Collaborators

2 joint publications

Eva Corey

2 joint publications

John K Lee

2 joint publications

Peter S Nelson

2 joint publications

Lawrence D True